JP2008509224A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509224A5
JP2008509224A5 JP2007525717A JP2007525717A JP2008509224A5 JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5 JP 2007525717 A JP2007525717 A JP 2007525717A JP 2007525717 A JP2007525717 A JP 2007525717A JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5
Authority
JP
Japan
Prior art keywords
medicament
hydroxytyrosol
homocysteine
subject
rich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028179 external-priority patent/WO2006020588A1/en
Publication of JP2008509224A publication Critical patent/JP2008509224A/ja
Publication of JP2008509224A5 publication Critical patent/JP2008509224A5/ja
Pending legal-status Critical Current

Links

JP2007525717A 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法 Pending JP2008509224A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60023804P 2004-08-09 2004-08-09
US67246005P 2005-04-18 2005-04-18
PCT/US2005/028179 WO2006020588A1 (en) 2004-08-09 2005-08-09 Olive compositions and methods for treating inflammatory conditions

Publications (2)

Publication Number Publication Date
JP2008509224A JP2008509224A (ja) 2008-03-27
JP2008509224A5 true JP2008509224A5 (https=) 2008-10-02

Family

ID=35907742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525717A Pending JP2008509224A (ja) 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法

Country Status (3)

Country Link
US (2) US20080300198A1 (https=)
JP (1) JP2008509224A (https=)
WO (1) WO2006020588A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006244136B2 (en) * 2005-05-09 2012-03-08 Monell Chemical Senses Center Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
US9789149B2 (en) * 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
JP5339373B2 (ja) * 2006-07-14 2013-11-13 ディーエスエム アイピー アセッツ ビー．ブイ． 組成物および炎症障害の治療、共治療または予防のためのその使用
JP5175481B2 (ja) * 2006-10-23 2013-04-03 エーザイフード・ケミカル株式会社 軟骨再生促進剤
JP2008120716A (ja) * 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
EP2134333A1 (en) * 2007-04-18 2009-12-23 DSM IP Assets B.V. Novel use of hydroxytyrosol and olive extracts/concentrates containing it
EP1982706A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol for the treatment of cartilage injury
EP2231136A1 (en) * 2007-12-12 2010-09-29 DSM IP Assets B.V. Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
EP2445483B1 (en) 2009-06-25 2017-04-26 McCord, Darlene Topical compositions and methods for wound care
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
EP2464247B1 (en) * 2009-08-10 2018-05-30 McCord, Darlene Nutritional supplements
WO2014085613A1 (en) 2012-11-30 2014-06-05 Mccord Darlene E Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
WO2014100715A2 (en) * 2012-12-21 2014-06-26 Ehrenkranz Joel R L Supplements and monitoring systems for dosing of the supplements
ITMI20131815A1 (it) * 2013-10-31 2015-05-01 Fattoria La Vialla Di Gianni Anton Io E Bandino L Uso antinfiammatorio di fitocomplessi liquidi da olive
WO2016046347A1 (en) * 2014-09-24 2016-03-31 Phytogen Medical Foods S.L Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
GR1008734B (el) 2014-11-26 2016-04-05 ΚΡΕΤΑ ΦΑΡΜ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ με δ.τ. "ΚΡΕΤΑ ΦΑΡΜ Α.Β.Ε.Ε." Υδατικο εκχυλισμα ελιας με μεταβολικες και καρδιο-προστατευτικες ιδιοτητες.
JP5956669B1 (ja) * 2015-12-18 2016-07-27 サンスター株式会社 低カロリーチョコレート組成物
US10342802B2 (en) 2016-10-04 2019-07-09 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
JP7079551B2 (ja) * 2016-10-04 2022-06-02 ニュートラマックス ラボラトリーズ，インコーポレイテッド ヒドロキシチロソールおよびボスウェリン酸を有する組成物
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
JP7304346B2 (ja) * 2017-11-08 2023-07-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ホモバニリルアルコール（ｈｖａ）、ｈｖａ異性体、このような化合物を含む組成物の作製方法、及びこのような化合物を使用する方法
JP2020193852A (ja) * 2019-05-28 2020-12-03 株式会社ファンケル 非侵襲的な血清亜鉛値の推定方法
BR112023005326A2 (pt) * 2020-09-24 2023-04-25 Mars Inc Composições alimentares e suas aplicações

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522119A (en) * 1980-12-23 1985-06-11 Fps Development Partnership Olive oil recovery
US4452744A (en) * 1980-12-23 1984-06-05 Fps Development Partnership Olive oil recovery
US4370274A (en) * 1980-12-23 1983-01-25 Fps Development Partnership Olive oil recovery
AU670742B2 (en) * 1991-03-21 1996-08-01 Parfums Christian Dior Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
WO1996014064A1 (en) * 1994-11-07 1996-05-17 Strecker, Robert, B. Method and composition for antiviral therapy
US5998641A (en) * 1997-01-31 1999-12-07 Unilever Patent Holdings Debittering of olive oil
US5714150A (en) * 1997-01-08 1998-02-03 Nachman; Leslie Method for producing extract of olive leaves
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DK1071338T3 (da) * 1998-04-14 2002-12-16 Unilever Nv Forstærkning af et vegetabilsk fedtstof med antioxidanter
US6936287B1 (en) * 1998-07-23 2005-08-30 Creagri, Inc. Water-soluble extract from olives
US6165475A (en) * 1998-07-23 2000-12-26 Creagri, Inc. Water-soluble extract from olives
WO2000004794A1 (en) * 1998-07-23 2000-02-03 Creagri, Inc. Water-soluble extract from olives
WO2000036936A2 (en) * 1998-12-22 2000-06-29 Unilever N.V. Food compositions fortified with anti-oxidants
AU768306B2 (en) * 1999-10-14 2003-12-04 Nisshin Oil Mills, Ltd., The Skin-care agents, skin antiaging agents, whitening agents and external skin preparations
US6358542B2 (en) * 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
US6437004B1 (en) * 2000-04-06 2002-08-20 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
CA2420893C (en) * 2000-09-01 2011-11-22 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
AU2002229784B2 (en) * 2001-02-15 2006-06-22 Consejo Superior De Investigaciones Cientificas Method for obtaining purified hydroxytyrosol from products and by-products derived from the olive tree
US6734449B2 (en) * 2001-11-20 2004-05-11 Nexpress Solutions Llc Device for detecting the location of an edge of a transparent material, web edge control and printing press
US6906100B2 (en) * 2002-02-08 2005-06-14 Lavipharm S.A. Compounds and compositions derived from olives and methods of the use thereof
US6743449B2 (en) * 2002-02-13 2004-06-01 Skinceuticals, Inc. Topical composition comprising olive leaf extract
CN1646093A (zh) * 2002-02-13 2005-07-27 克雷农业公司 治疗炎症和与aids关联的神经紊乱的方法和组合物
ES2193874B1 (es) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
WO2005041999A1 (en) * 2003-10-21 2005-05-12 Motion Potion, Inc. Composition to enhance joint function and repair

Similar Documents

Publication Publication Date Title
JP2008509224A5 (https=)
GB0410266D0 (en) Treatment of apoptosis
JP2002522485A5 (https=)
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
JP2020500864A5 (https=)
RU2009119258A (ru) Способ лечения воспалительных заболеваний кишечника
Troester et al. Pediatric sleep pharmacology: a primer
Niino et al. Optimal clinical pathway for the patient with type B acute aortic dissection
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
Wawrzyniak et al. Comparison of clonidine and midazolam premedication before endoscopic sinus surgery: results of clinical trial
EP3883557A1 (en) Composition for use in the prevention and/or symptomatic treatment of irritable bowel syndrome
Prousky The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis.
US10179122B2 (en) Use of melatonin
US20220370347A1 (en) Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
RU2004121780A (ru) Способ лечения
KR20120015289A (ko) 피브레이트의 신규한 용도
JP2006282507A (ja) 下痢の予防および／または治療薬
JP6032681B2 (ja) 排尿障害の予防・治療剤
Botea Analgesics
JP2006045200A (ja) 間質性膀胱炎の治療薬
IT202100032543A1 (it) Composizione comprendente gelatina, psillio e rosolaccio e suoi usi per il trattamento della sindrome dell’intestino irritabile
Daneel Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives
WO2009031029A1 (en) Treatment of cns and pain disorders
HUP0700383A2 (en) Use of b6, b12 vitamines, folic acid and rutosid for the prevention and treatment of venous trombosis
Liatsikos et al. Doxazosin for the management of distal ureteral stones